By G HossainPosted on September 10, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Encoded Therapeutics’ lead asset ETX101 is a gene therapy being tested for Dravet syndrome. Phase 1/2 data showed substantial reductions in seizures. Encoded raises $275M series F for Dravet syndrome gene therapy Post navigation From process to intelligence: How AI is reshaping people strategy in life sciencesDrugmakers cherry pick launch regions as MFN creates ‘policy environment like an earthquake’